Technical Analysis for TOCA - Tocagen Inc.

Grade Last Price % Change Price Change
grade F 5.34 -3.26% -0.18
TOCA closed down 3.26 percent on Tuesday, July 23, 2019, on 45 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Aug 5

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TOCA trend table...

Date Alert Name Type % Chg
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Down 3 Days in a Row Weakness -3.26%
Down 4 Days in a Row Weakness -3.26%
Oversold Stochastic Weakness -3.26%
MACD Bearish Signal Line Cross Bearish -6.15%

Older signals for TOCA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Tocagen Inc. (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the deoxyribonucleic acid (DNA) of cancer cells. Its lead product candidates are vocimagene amiretrorepvec (Toca 511) and flucytosine extended release (Toca FC). Toca 511 is an investigational injectable retroviral replicating vector (RRV) that encodes a prodrug activator enzyme, cytosine deaminase (CD). Toca FC is an investigational extended-release version of 5-fluorocytosine (5-FC), a prodrug that is inactive as an anti-cancer drug. As of February, 2017, Tocagen has completed enrollment of the Phase II portion with 187 patients.
Biotechnology Cancer Life Sciences Biology Gene Therapy Applied Genetics
Is TOCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.8
52 Week Low 4.13
Average Volume 374,956
200-Day Moving Average 9.5044
50-Day Moving Average 6.1064
20-Day Moving Average 6.03
10-Day Moving Average 5.771
Average True Range 0.3978
ADX 10.15
+DI 14.4648
-DI 22.0383
Chandelier Exit (Long, 3 ATRs ) 5.5766
Chandelier Exit (Short, 3 ATRs ) 6.4534
Upper Bollinger Band 6.6774
Lower Bollinger Band 5.3826
Percent B (%b) -0.03
BandWidth 21.472637
MACD Line -0.1942
MACD Signal Line -0.1544
MACD Histogram -0.0398
Fundamentals Value
Market Cap 105.78 Million
Num Shares 19.8 Million
EPS -6.18
Price-to-Earnings (P/E) Ratio -0.86
Price-to-Sales 4252.02
Price-to-Book 2.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.88
Resistance 3 (R3) 5.91 5.77 5.79
Resistance 2 (R2) 5.77 5.63 5.75 5.76
Resistance 1 (R1) 5.55 5.54 5.48 5.52 5.73
Pivot Point 5.41 5.41 5.37 5.39 5.41
Support 1 (S1) 5.19 5.27 5.12 5.16 4.95
Support 2 (S2) 5.05 5.18 5.03 4.92
Support 3 (S3) 4.83 5.05 4.89
Support 4 (S4) 4.80